trending Market Intelligence /marketintelligence/en/news-insights/trending/y7MwN_P8tY_CsUfJjgQ8iA2 content esgSubNav
In This List

Asterias Biotherapeutics to raise $10.4M

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Asterias Biotherapeutics to raise $10.4M

Asterias Biotherapeutics Inc. is looking to raise $10.4 million via the sale of 4 million shares priced at $2.60 apiece.

The company intends to sell the series A common stock in a registered direct offering with certain institutional investors. The offering is expected to close by Oct. 18.

Asterias intends to use the net proceeds for clinical trial and process development activities related to its AST-OPC1 program, research and development, capital expenditures, working capital, and other general corporate purposes.

Chardan is acting as the sole placement agent in connection with the offering.